Current path: Executive Management | |
|
Executive Management
 |
Erik Nauerby - Managing Director. Mr. Nauerby joined Millimed in January, 2005 in the position of Director of Finance. Previously Mr. Nauerby was CFO of Danish Biotech company 7TM Pharma A/S for 2½ years and prior to that Director of Business Controlling and Board Reporting at Novozymes A/S - a Danish world leader in the market for industrial enzymes. Mr. Nauerby holds an Executive MBA from SIMI at Copenhagen. |
 |
Finn M. Ulrich - Vice President of Research & Development of Millimed Holdings Inc., Mr. Ulrich joined Millimed in September 2004. Between 1991 and 2004 Mr. Ulrich held various positions within Novo Nordisk A/S, Denmark. From 1996 to 2001 he was Director of Medical Device Operation and from 2001 to 2004 R&D Project Director. Before working with Novo Nordisk, he was employed as an R&D engineer with Brüel & Kjær A/S, a diagnostic equipment manufacturer from 1986 to 1991. Finn earned his Master of Science degree in Electronical Engineering from the Technical University of Denmark and holds a Bachelor of Commerce degree from Copenhagen Business School. He has extensive experience within R&D and manufacturing from the medtech industry, quality assurance and GMP as well as pharmaceutical engineering. | | | |
|
|